Citigroup Inc Rani Therapeutics Holdings, Inc. Call Options Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
36Shares Held
5.8MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.45 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$951,1690.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$661,4021.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$600,9790.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$405,6750.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $32.8M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...